Dr. Antonio Speciale is Researcher (RTD-B, SSD BIO/14) at the department of Chemical, Biological, Pharmaceutical and Environmental Sciences, Università degli Studi di Messina, Italy. He received a degree in Chimica e Tecnologie Farmaceutiche in 2004, and obtained a Ph.D. in Toxicology in 2009, and a degree as Specialist in Pharmacognosy in 2013 at the University of Messina, and completed is training in the Pharmacogenetics Working Group at Virginia Commonwealth University (Richmond, VA, USA). Dr. Speciale teaches the course of Pharmacovigilance and Pharmacoeconomics - Chemotherapy and Immunofarmacology in the Master degree in Pharmacy, and teaches the course of Evidence-Based Pharmacotherapy in the Specialization School in Hospital Pharmacy at the Università degli Studi di Messina, Italy. His research interests are mainly focused in elucidating the mode-of-action of bioactive compounds by using in vitro cellular models. In particular, his research focuses on natural products and their capacity to modulate cellular adaptive response pathways, such as Nrf2/Keap1 pathway and NF-κB pathway, and in the discovery of natural products-based anticancer agents. Up to November 13, 2018, as downloaded from ISI he has got 47 (51 Scopus) papers, 602 (688 Scopus, 876 Google Scholar) times cited with an Average Citation per Year of 51.92, an Average Citation per Item of 10.42 and an H-index of 15 (15 Scopus, 17 Google Scholar with i10-index of 26), with a Total Impact Factor of 140.2